Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics
Ana Maria Volpato, Alexandra I. Zugno, João Quevedo
Brazilian Journal of Psychiatry (2013) Vol. 35, Iss. 3, pp. 295-304
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Mark R. Libowitz, Erika L. Nurmi
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 61
Association between antipsychotic medication and clinically relevant weight change: meta-analysis
Bea Campforts, Marjan Drukker, Joost Crins, et al.
BJPsych Open (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Association between body mass index and subcortical brain volumes in bipolar disorders–ENIGMA study in 2735 individuals
Sean R. McWhinney, Christoph Abé, Martin Alda, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6806-6819
Open Access | Times Cited: 35
Mechanism and treatments of antipsychotic-induced weight gain
Wujie Ye, Jingyu Xing, Zekai Yu, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 6, pp. 423-433
Closed Access | Times Cited: 14
Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder
Ljubica Tasić, Acioly L.T. Larcerda, João Guilherme de Moraes Pontes, et al.
Journal of Psychiatric Research (2019) Vol. 119, pp. 67-75
Closed Access | Times Cited: 40
Evaluating the Significance of Obesity or Excessive Weight in Various Mental Health Disorders: A Systematic Review
Taiwo A Falaiye, Okelue E Okobi, Chidimma I Oramu, et al.
Cureus (2025)
Open Access
Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
Elena G. Kornetova, А. Н. Корнетов, Irina A. Mednova, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 32
Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view
Vítor Ferreira, Diana Grajales, Ángela M. Valverde
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2019) Vol. 1865, Iss. 2, pp. 158534-158534
Open Access | Times Cited: 32
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
Francky Teddy Endomba, Aurel T. Tankeu, Jan René Nkeck, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia
Fumitoshi Kodaka, Kazutaka Ohi, Yuka Yasuda, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 8, pp. 557-565
Open Access | Times Cited: 7
Crosstalk of hypothalamic chemerin, histamine, and AMPK in diet-and olanzapine-induced obesity in rats
Doaa M. Samy, Dalia K. Mostafa, Doaa A. Abdelmonsif, et al.
Life Sciences (2021) Vol. 284, pp. 119897-119897
Closed Access | Times Cited: 13
Atypical antipsychotics and metabolic syndrome
Abigail Perez Rodriguez, Kazuhiro Tajima-Pozo, Adrian Lewczuk, et al.
Cardiovascular Endocrinology (2015) Vol. 4, Iss. 4, pp. 132-137
Open Access | Times Cited: 12
Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study
Tomohiko Kimura, Akifumi Kanai, Hiroyuki Muraoka, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 1, pp. 158-164
Open Access | Times Cited: 1
Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine
Tatjana Nikolić, Milan Petronijević, Jelena Sopta, et al.
BMC Pharmacology and Toxicology (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine
Robert S. Brody, Charles Liss, Heather Wray, et al.
International Clinical Psychopharmacology (2015) Vol. 31, Iss. 1, pp. 34-41
Closed Access | Times Cited: 11
Significant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subject
Tongeji E. Tungaraza
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 5, pp. 335-342
Open Access | Times Cited: 9
Optimization of Early Diagnosis of Glucose Metabolism Impairment for Patients Receiving Antipsychotic Medications at the Outpatient Psychiatric Clinic of the University Teaching Hospital, Lusaka, Zambia
Makame Haji Pandu, Anatolii Tsarkov, Petro Petlovanyi, et al.
European Journal of Medical and Health Sciences (2022) Vol. 4, Iss. 4, pp. 75-83
Open Access | Times Cited: 6
What evidence is there to show which antipsychotics are more diabetogenic than others?
Cátia Jesus, Inês Jesus, Mark Agius
PubMed (2015) Vol. 27 Suppl 1, pp. S423-8
Closed Access | Times Cited: 7
Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase®
Florentia Kaguelidou, Zaba Valtuille, Geneviève Durrieu, et al.
Drug Safety (2022) Vol. 46, Iss. 1, pp. 77-85
Closed Access | Times Cited: 5
Atypical antipsychotics olanzapine and clozapine increase bone loss in female rats with experimental periodontitis
Mariana Alves Soares, André Luiz Amorim da Costa, Natália L. C. Silva, et al.
Journal of Periodontal Research (2022) Vol. 58, Iss. 2, pp. 283-295
Closed Access | Times Cited: 5
Beta-cell Function and Metabolic Clearance Rate of Glucose in Patients with Major Mental Health Disorders on Antipsychotic Drug Treatment
Kehinde Sola Akinlade, Sheu Kadiri Rahamon, Victor Olufolahan Lasebikan
Journal of the National Medical Association (2018) Vol. 110, Iss. 5, pp. 504-511
Closed Access | Times Cited: 5
Metabolic Response to Olanzapine in Healthy Chinese Subjects with rs7093146 Polymorphism in Transcription Factor 7‐like 2 Gene (TCF7L2): A Prospective Study
Qing Li, Dong Guo, Hong Yang, et al.
Basic & Clinical Pharmacology & Toxicology (2016) Vol. 120, Iss. 6, pp. 601-609
Open Access | Times Cited: 3
Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution
Marie Lenski, Jonathan Sidibé, Mehdi Gholam‐Rezaee, et al.
Clinical and Translational Science (2021) Vol. 14, Iss. 6, pp. 2544-2555
Open Access | Times Cited: 4
Perfil metabólico y factores asociados en pacientes con esquizofrenia bajo tratamiento con antipsicóticos que acuden a consulta externa en el Instituto Nacional de Salud Mental (Perú).
Miguel A. Ricapa, Luis B. Guimas, Ray Ticse
Revista de Neuro-Psiquiatría (2017) Vol. 79, Iss. 4, pp. 216-216
Open Access | Times Cited: 3
Effects of atypical antipsychotics on serum asprosin level and other metabolic parameters in patients with schizophrenia
Kiumarth Amini, Mohammad‐Javad Motallebi, Kimia Bakhtiari, et al.
Human Psychopharmacology Clinical and Experimental (2024) Vol. 39, Iss. 5
Closed Access
Page 1 - Next Page

Scroll to top